JPWO2022103960A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022103960A5
JPWO2022103960A5 JP2023528356A JP2023528356A JPWO2022103960A5 JP WO2022103960 A5 JPWO2022103960 A5 JP WO2022103960A5 JP 2023528356 A JP2023528356 A JP 2023528356A JP 2023528356 A JP2023528356 A JP 2023528356A JP WO2022103960 A5 JPWO2022103960 A5 JP WO2022103960A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
haloalkyl
heterocycloalkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023528356A
Other languages
English (en)
Japanese (ja)
Other versions
JP7605984B2 (ja
JP2023549494A5 (https=
JP2023549494A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/058978 external-priority patent/WO2022103960A1/en
Publication of JP2023549494A publication Critical patent/JP2023549494A/ja
Publication of JPWO2022103960A5 publication Critical patent/JPWO2022103960A5/ja
Publication of JP2023549494A5 publication Critical patent/JP2023549494A5/ja
Application granted granted Critical
Publication of JP7605984B2 publication Critical patent/JP7605984B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023528356A 2020-11-13 2021-11-11 ジクロロフェノールhsd17b13阻害剤およびその使用 Active JP7605984B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063113557P 2020-11-13 2020-11-13
US202063113555P 2020-11-13 2020-11-13
US63/113,557 2020-11-13
US63/113,555 2020-11-13
US202163170855P 2021-04-05 2021-04-05
US63/170,855 2021-04-05
US202163225282P 2021-07-23 2021-07-23
US63/225,282 2021-07-23
PCT/US2021/058978 WO2022103960A1 (en) 2020-11-13 2021-11-11 Dichlorophenol hsd17b13 inhibitors and uses thereof

Publications (4)

Publication Number Publication Date
JP2023549494A JP2023549494A (ja) 2023-11-27
JPWO2022103960A5 true JPWO2022103960A5 (https=) 2024-10-23
JP2023549494A5 JP2023549494A5 (https=) 2024-10-23
JP7605984B2 JP7605984B2 (ja) 2024-12-24

Family

ID=81602609

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023528356A Active JP7605984B2 (ja) 2020-11-13 2021-11-11 ジクロロフェノールhsd17b13阻害剤およびその使用

Country Status (11)

Country Link
US (3) US11827619B2 (https=)
EP (1) EP4244210A4 (https=)
JP (1) JP7605984B2 (https=)
KR (1) KR102852264B1 (https=)
CN (1) CN116670118B (https=)
AU (1) AU2021377248B2 (https=)
CA (1) CA3198024A1 (https=)
IL (1) IL302764A (https=)
MX (1) MX2023005550A (https=)
TW (1) TWI893238B (https=)
WO (1) WO2022103960A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116670118B (zh) 2020-11-13 2026-02-06 伊尼制药公司 二氯苯酚hsd17b13抑制剂及其用途
EP4320111A4 (en) * 2021-04-05 2025-03-12 Inipharm, Inc. HYDROXYPYRIDINE-TYPE HSD17B13 INHIBITORS AND USES THEREOF
JP2025503953A (ja) * 2022-01-26 2025-02-06 イニファーム,インク. 2-置換チアゾールhsd17b13阻害剤およびその使用
DK4514782T3 (da) 2022-05-19 2025-12-15 Astrazeneca Ab Heteroaromatiske amidoforbindelser, der er nyttige ved behandling af leversygdomme
WO2025024682A1 (en) * 2023-07-26 2025-01-30 Inipharm, Inc. Methods of using dichlorophenol hsd17b13 inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2694711A (en) 1952-12-02 1954-11-16 American Cyanamid Co Quinazolone antimalarial compounds
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
DE19642451A1 (de) 1996-10-15 1998-04-16 Merck Patent Gmbh Aminothiophencarbonsäureamide
WO2004085382A1 (ja) 2003-03-27 2004-10-07 Kirin Beer Kabushiki Kaisha 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
WO2006008545A2 (en) 2004-07-22 2006-01-26 Astex Therapeutics Limited Thiazole and isothiazole derivatives as protein kinase inhibitors
US20070010537A1 (en) 2004-08-20 2007-01-11 Kazumasa Hamamura Fused pyramidine derivative and use thereof
EP1896476A2 (en) 2005-06-28 2008-03-12 Orchid Research Laboratories Limited Novel pyrazolopyrimidinone derivatives
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
CN101287728A (zh) 2005-08-17 2008-10-15 先灵公司 新的高亲和力噻吩基和呋喃基激酶配体
DK2428513T3 (en) 2006-09-26 2017-08-21 Celgene Corp 5-substituted quinazolinone derivatives as anti-cancer agents
US20080255161A1 (en) * 2007-04-11 2008-10-16 Dmitry Koltun 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
US8703768B2 (en) 2010-06-09 2014-04-22 Hoffmann-La Roche Inc. Nitrogen containing heteroaryl compounds
US20120165330A1 (en) * 2010-12-22 2012-06-28 Sirtris Pharmaceuticals, Inc. Quinazolinone and related analogs as sirtuin modulators
CN103288771B (zh) 2012-02-29 2014-12-03 中国中化股份有限公司 异噻唑类化合物及其作为杀菌剂的用途
WO2013165606A1 (en) 2012-05-04 2013-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of the relaxin receptor 1
CA2935495C (en) 2013-01-14 2021-04-20 Deuterx, Llc 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
CN105524053B (zh) 2014-10-19 2020-06-05 广东东阳光药业有限公司 四氢苯并噻吩化合物
EP3804725A3 (en) 2014-11-17 2021-07-07 Rhode Island Hospital Nanomaterial compositions, synthesis, and assembly
DK3356345T3 (da) 2015-09-30 2024-02-12 Max Planck Gesellschaft Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
EP3404024B1 (en) 2016-01-14 2020-11-18 Kangpu Biopharmaceuticals, Ltd. Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications
KR101870968B1 (ko) 2016-02-02 2018-06-25 부산대학교 산학협력단 Ppar, fxr 및 ampk 활성화 효능을 갖는 신규 티오펜 화합물 또는 이의 약제학적으로 허용 가능한 염 및 이의 의학적 용도
SI3497091T1 (sl) 2016-08-15 2020-11-30 Eli Lilly And Company Kondenzirani derivati tiofena uporabni kot inhibitorji NAPI-IIB
TWI762634B (zh) 2017-05-05 2022-05-01 大陸商上海赫普化醫藥技術有限公司 胺基-芳基-苯甲醯胺化合物及其使用方法
BR112020015743A2 (pt) 2018-02-08 2020-12-15 Enyo Pharma Derivados de tiofeno não fundido e seus usos
AU2019240214A1 (en) 2018-03-21 2020-09-17 Ionis Pharmaceuticals, Inc. Modulation of HSD17B13 expression
CA3110520A1 (en) 2018-08-24 2020-02-27 Terns, Inc. Thyroid hormone receptor beta agonist compounds
EP3994125B1 (en) 2019-07-02 2025-12-24 Regeneron Pharmaceuticals, Inc. Modulators of hsd17b13 and methods of use thereof
WO2021211974A1 (en) 2020-04-18 2021-10-21 Inipharm, Inc. Hsd17b13 inhibitors and uses thereof
WO2022020714A1 (en) 2020-07-24 2022-01-27 Inipharm, Inc. Thiophene hsd17b13 inhibitors and uses thereof
EP4185380A4 (en) 2020-07-24 2024-08-21 Inipharm, Inc. Quinazolinone hsd17b13 inhibitors and uses thereof
EP4192448A1 (en) 2020-08-05 2023-06-14 ENYO Pharma Thiophen compounds for use in the treatment of renal fibrosis
WO2022040324A1 (en) 2020-08-18 2022-02-24 Metrea Biosciences, Inc. COMPOUNDS AND METHODS OF MODULATING 17β-ΗYDROXYSTEROID DEHYDROGENASE TYPE 13
IL301768A (en) 2020-09-30 2023-05-01 Fl2022 001 Inc Hsd17b13 inhibitors and uses thereof
US20240083853A1 (en) 2020-09-30 2024-03-14 Fl2022-001, Inc. Hsd17b13 inhibitors and uses thereof
CA3194376A1 (en) 2020-09-30 2022-04-07 Andrew R. Hudson Hsd17b13 inhibitors and uses thereof
US20230416802A1 (en) 2020-11-06 2023-12-28 Inipharm, Inc. Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatment
CN116670118B (zh) 2020-11-13 2026-02-06 伊尼制药公司 二氯苯酚hsd17b13抑制剂及其用途
WO2022216627A1 (en) 2021-04-05 2022-10-13 Inipharm, Inc. Thiazole/isothiazole hsd17b13 inhibitors and uses thereof
EP4320111A4 (en) 2021-04-05 2025-03-12 Inipharm, Inc. HYDROXYPYRIDINE-TYPE HSD17B13 INHIBITORS AND USES THEREOF
CN118103038A (zh) 2021-08-20 2024-05-28 英安塔制药有限公司 17β-羟基类固醇脱氢酶13型抑制剂及其使用方法
JP2025503953A (ja) 2022-01-26 2025-02-06 イニファーム,インク. 2-置換チアゾールhsd17b13阻害剤およびその使用
JP2025523357A (ja) 2022-06-09 2025-07-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Hsd17b13阻害剤

Similar Documents

Publication Publication Date Title
JPWO2022225934A5 (https=)
JPWO2022251502A5 (https=)
JP2021183609A5 (https=)
JP2021522280A5 (https=)
JP2022137237A5 (https=)
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
RU2016110016A (ru) Алкиниловые спирты и способы их применения
JP2013541503A5 (https=)
JP2005533811A5 (https=)
CA2653034A1 (en) Macrocyclic oximyl hepatitis c protease inhibitors
RU2013132683A (ru) Ингибиторы репликации вирусов гриппа
JP2010518128A5 (https=)
JP2009536221A5 (https=)
JP2015051994A5 (https=)
RU2016110021A (ru) Алкиниловые спирты и способы их применения
JP2017536395A5 (https=)
JP2018533593A5 (https=)
JP2009526868A5 (https=)
IL293848A (en) Triterpene saponin analogues, methods of producing same, compositions comprising same and uses thereof
JP2009541224A5 (https=)
JPWO2022103960A5 (https=)
JPWO2019241292A5 (https=)
JPWO2023022216A5 (https=)
JPWO2022020730A5 (https=)
JPWO2023072257A5 (https=)